Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome that occurs because of uncontrolled immune cell activation and can present as a primary or acquired disorder. It is an illness with a high mortality rate that has been increasing in incidence over the past decade. There are few reports of allopurinol-induced HLH. This case describes a patient who was initially diagnosed with drug-induced liver injury secondary to allopurinol and subsequently diagnosed with HLH secondary to allopurinol. The discussion highlights the pathophysiology, clinical findings, diagnostic work-up, and treatment of HLH, along with mentioning interventions that focus on prevention of these diseases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
